Companies · Healthtech

Tava Health, Inc.

SALT LAKE CITY · Healthtech · refined from filed group “Other Technology

Diligence memoA one-page analyst read on Tava Health, Inc. — recommendation, valuation, rhythm, risks.
$28.9M
Total raised · real
3
Rounds
1.6×
Latest step-up
Top 16%
Sector rank · raised
Series B
Latest stage · inferred · Fri Dec 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Tava Health, Inc. looks fair against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.78× the median modeled value of Series B Healthtech companies in 2022–2024 (98 peers) — value vs value, same stage and era.
  • Within the normal band (78% of peer median) for its niche.
At-risk
  • Last raise 2.5 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Tava Health, Inc. is one of 2138 Healthtech companies tracked from SALT LAKE CITY. By capital raised it ranks in the upper tier (ahead of 85% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
4
Investors (latest)
2019
Year incorporated
2023-12-15
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeed · 2020-04-14 Raised $2.9M (real) Modeled valuation $82M (est)$2.9M$82MSeed2020Series A · 2021-11-23 Raised $10.0M (real) Modeled valuation $133M (est)$10.0M$133MSeries A2021Series B · 2023-12-15 Raised $16M (real) Modeled valuation $129M (est)$16M$129MSeries B2023+$10.0M+$16MCumulative $29M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.9M · 2020
Series A$10.0M · 2021
Series B$16.0M · 2023

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$129.5M
Base estimate est.
$37.6M
Conservative case
$257.1M
Upside case
$88.9M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Seed · modeled $81.7M · 2020-04-142020Series A · modeled $133.3M · 2021-11-23Series B · modeled $129.5M · 2023-12-152023
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
2.5 yr
Elapsed time used
2.5 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
22 mo
Avg between rounds
$7.9M/yr
Capital velocity
6.2 yr
On record since
2020
First round
3
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 6.5× above median
This company$28.9M
Sector median$4.5M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.9× of median
This company$16.0M
Sector median$18.3M
Modeled value — vs sector median (estimate, all stages) 3.8× above median
This company$129.5M
Sector median$33.8M

Raised more than 85% of sector peers (real $). Modeled value above 81% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #64 of 98.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)Casana Care, Inc. · Series B Raised $56.4M · modeled $607.4M (est)Mendel Health Inc. · Series B Raised $52.7M · modeled $570.4M (est)Bicycle Health Inc. · Series B Raised $61.4M · modeled $492.2M (est)Brave Health, Inc. · Series B Raised $38.6M · modeled $485.3M (est)Flume Health, Inc. · Series B Raised $35.9M · modeled $445.6M (est)Healthy America, LLC · Series B Raised $31.0M · modeled $435.5M (est)Moxe Health Corp · Series B Raised $34.8M · modeled $403.8M (est)Kintsugi Mindful Wellness, Inc. · Series B Raised $25.0M · modeled $370.1M (est)Invoq Health, Inc. · Series B Raised $41.5M · modeled $362.2M (est)Folx Health, Inc. · Series B Raised $59.3M · modeled $355.4M (est)Recuro Health, Inc. · Series B Raised $44.2M · modeled $339.7M (est)Orchard Healthcare, Inc. · Series B Raised $34.8M · modeled $338.6M (est)Tava Health, Inc. (this company) Raised $28.9M · modeled $129.5M (est)Tava Health, Inc.
CompanyStageRaised · realValue · estvs peer med.
Casana Care, Inc.Series B$56.4M$607.4M3.68×
Mendel Health Inc.Series B$52.7M$570.4M3.45×
Bicycle Health Inc.Series B$61.4M$492.2M2.98×
Brave Health, Inc.Series B$38.6M$485.3M2.94×
Flume Health, Inc.Series B$35.9M$445.6M2.70×
Healthy America, LLCSeries B$31.0M$435.5M2.64×
Moxe Health CorpSeries B$34.8M$403.8M2.45×
Kintsugi Mindful Wellness, Inc.Series B$25.0M$370.1M2.24×
Invoq Health, Inc.Series B$41.5M$362.2M2.19×
Folx Health, Inc.Series B$59.3M$355.4M2.15×
Recuro Health, Inc.Series B$44.2M$339.7M2.06×
Orchard Healthcare, Inc.Series B$34.8M$338.6M2.05×
Tava Health, Inc. this companySeries B$28.9M$129.5M0.78×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.9M2020-04-14$14.7M$81.7M90%
Series A$10.0M2021-11-23$45.5M$133.3M90%
Series B$16.0M2023-12-15$88.9M$129.5M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.9M2020-04-14
    • First recorded raise — entered as Seed.
    • 8 investors on this round.
  2. Series A$10.0M2021-11-23
    • Raised 19 mo later, in step with the ~14 mo sector norm.
    • Round 3.4× larger than the prior — scaling up.
    • 13 investors on this round.
  3. Series B$16.0M2023-12-15
    • Raised again after 25 mo — slower than the ~14 mo sector norm.
    • Round 1.6× larger than the prior — scaling up.
    • 4 investors on this round.
Intelligence
2025 ~Q4
Modeled next raise · ~22mo cadence
$25.6M
Modeled next size est.range $16.6M$41.0M
1.6×
Last step-up
$7.9M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Randall Lloyd3 other2020-04
Ilana Stern2 other2021-11
Dallen Allred1 other2020-04
Jason Ockey1 other2020-04
Kapil Desai1 other2023-12
Matt Christensen1 other2021-11
Spencer Gardner2020-04
Registry & provenance

Tava Health, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1810141
SEC CIK
2019
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Sevaro Health IncHealthtechSeries B$46.0M$174.9Mnetwork1 shared operator · same sector · same stage
Artemis Health Inc.HealthtechSeries B$46.4M$566.7Mnetwork1 shared operator · same sector · same stage
Owlet Baby Care Inc.HealthtechSeries B$29.5M$145.4Msame sector · same stage
Layer Health, Inc.HealthtechSeries B$29.5M$172.1Msame sector · same stage
Health Precision Inc.HealthtechSeries B$29.8M$98.9Msame sector · same stage
Puzzle Medical Devices Inc.HealthtechSeries B$30.0M$168.5Msame sector · same stage
BrightSpring Health Services, Inc.HealthtechSeries B$30.0M$192.6Msame sector · same stage
Charta Health, Inc.HealthtechSeries B$30.1M$148.7Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
TAS Medical, Inc.HealthtechSeries A$19.8M92%
Cava Healthcare Inc.HealthtechPre-Seed$6.5M88%
Vanna Health, Inc.HealthtechSeries B$25.4M88%
Heka Health, Inc.HealthtechPre-Seed$12.2M87%
Nava Health Md, Inc.HealthtechSeed$458K87%
Healthe, Inc.HealthtechSeries B$464.8M87%
HealthSnap, Inc.HealthtechSeries B$183.0M86%
Tabu Health, Inc.HealthtechSeed$83.6M86%
Frequently asked
How much funding has Tava Health, Inc. raised?
Tava Health, Inc. has raised approximately $28.9M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Tava Health, Inc.'s estimated valuation?
Provath's modeled valuation for Tava Health, Inc. is approximately $129.5M (modeled range $37.6M–$257.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Tava Health, Inc. at?
Tava Health, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Fri Dec 15.
What does Tava Health, Inc. do and where is it based?
Tava Health, Inc. operates in the Healthtech sector, based in SALT LAKE CITY.
Explore related

See where Tava Health, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Tava Health, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.